• SELECT SITE CURRENCY
Select a currency for use throughout the site
U.S. SNP Detection Technology Markets
Frost & Sullivan, November 2002
Demand for SNP Analysis Increases Rapidly due to Pharmacogenomics
As the immense potential of pharmacogenomics (the study of how an individual's genetic inheritance affects the body's response to drugs) and personalized medicine are being realized, gene expression and genomic tools are becoming vital to the research process. Analysis of genetic variations such as single nucleotide polymorphisms (SNPs) in the human genome and their relation to health, disease, and drug response is expected to provide invaluable information toward the development of personalized medicines.
This Frost & Sullivan research analyzes the U.S. markets for SNP detection technology. It provides valuable analyses of market drivers and restraints and gives forecasts identifying the areas of growth. The study covers academic research, government laboratory research, early stage pharmaceutical research including candidate gene and disease association studies, clinical trials, and health management and diagnostics.
Potential to Screen Drugs and Isolate Dangerous Compounds Early Spurs SNP Studies
Many pharmaceutical companies are primarily concerned with determining the potentially dangerous compounds in their pipeline, reports the author of this study. SNPs can help researchers to identify the therapeutics that will have the greatest potential for avoidance of adverse effects and also improve therapeutics by analyzing how genetic variations influence drug response.
The screening of drug candidates using SNPs reduces costs in the drug development process and the revenues generated can fund further studies. Technological improvement and growing consumer demand are bringing down the price of genotyping. As the prices decline, more researchers have the opportunity to use SNPs in their research.
Pharmaceutical Companies Creating Sample Banks for Future Research
Pharmaceutical companies beginning to understand the importance of having sample populations and an increasing number of samples are being banked as they anticipate a need for future genotyping.
Sample banking allows DNA from a sample of patients to be tested in retrospect if they emerge from the trial with unusual responses to a particular drug. This can help companies avoid the high costs of association studies, by genotyping only when necessary, notes the author.
New opportunities for SNPs can be found in existing markets such as forensics and paternity testing. The creation of a genome-wide haplotype map is also driving the need for high throughput SNP genotyping and analysis. SNPs are being used in studies by plant and animal researchers and geneticists as well.
2Research Methodology Scope and Definitions
1Objectives and Purpose
4Glossary of Terms
3Technology and Applications for SNP Detection
A.Definition and Application of SNPs
1Overview and Definition
2The SNP Life Cycle
4SNPs in Drug Discovery and Development
7Markets for SNP Technology
4Industry Challenges and Strategies
1Introduction to Challenges
5SNP Technology Detection Technology Market (US)
A.Total Market Analysis for the US SNP Detection Technology Market
5Market Share Analysis
6Market Engineering Measurements
B.Competitive Structure and Analysis
2Mergers and Acquisitions
C.SNP Detection Technology Market Revenues Forecasts
1Total Market Revenues
2Basic Research Academic - Institutional and Government Laboratories
3Early Pharmaceutical Research
5Health Management and Diagnostics
6Market Engineering Awards
1Market Engineering Leadership Award
2Product Line Strategy